Male Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2013-05-17
Clinical Trial Update: Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer [Phase 1]
This clinical trial update notes the withdrawal of a Phase 1 study of ex vivo-expanded HER2-specific T cells with cyclophosphamide following…